FDA record · 503B outsourcing facility

Mark Cuban Cost Plus Manufacturing and Compounding, LLC: FDA 503B outsourcing facility record

Mark Cuban Cost Plus Manufacturing and Compounding, LLC in Dallas, TX is on FDA's register of 503B outsourcing facilities. Registered since Nov 2, 2022; last FDA inspection Jan 28, 2026; Form 483 issued at that inspection: Yes; action FDA lists: FMD-145 Letter Issued 6/5/2025. Register updated by FDA Sep 30, 2026.

Julian CaraulaniFounder, PriceTracker GLP-1FDA register read Oct 3

Status: Registered since Nov 2, 2022; last FDA inspection Jan 28, 2026.

What FDA’s register states

FDA register entry for Mark Cuban Cost Plus Manufacturing and Compounding, LLC
Field	What FDA’s record states	Source
Facility	Mark Cuban Cost Plus Manufacturing and Compounding, LLC	FDA register
Location	Dallas, TX	FDA register
First registered	Nov 2, 2022	FDA register
Most recent registration	Dec 14, 2024	FDA register
Last FDA inspection	Jan 28, 2026	FDA register
Form 483 issued	Yes	FDA register
Recall conducted	No	FDA register
Action based on last inspection	FMD-145 Letter Issued 6/5/2025	FDA register
Earlier compounding action	Not published by FDA	n/a
Intends to compound sterile drugs from bulk	Yes	FDA register

Registration is a filing, not an approval.A Form FDA 483 lists what investigators observed; in FDA’s words it “does not constitute a final agency determination of whether any condition is in violation of the FD&C Act or any relevant regulations.” “Open” means FDA has not determined whether further action will be taken.

Source

Copied from FDA’s Registered Outsourcing Facilities table ↗, updated by FDA Sep 30, 2026, read Oct 3, 2026. The table does not include State Board of Pharmacy actions. All 98 registered facilities